Your browser doesn't support javascript.
loading
Preparation of 4-(4'-Hydroxyanilino)-5-anilinophthalimide and 4,5-Bis-(4'-hydroxyanilino)-phthalimide by Microbial Hydroxylation.
Weidner, S; Goeke, K; Trinks, U; Traxler, P; Ucci-Stoll, K; Ghisalba, O.
Afiliação
  • Weidner S; b Institute of Enzyme Technology, Heinrich-Heine-University Düsseldorf, Research Center Jülich.
  • Goeke K; a Novartis Pharma AG, Research, Core Technology Area, Expertise Bioreactions.
  • Trinks U; a Novartis Pharma AG, Research, Core Technology Area, Expertise Bioreactions.
  • Traxler P; c Oncology Research, Novartis Pharma Inc.
  • Ucci-Stoll K; a Novartis Pharma AG, Research, Core Technology Area, Expertise Bioreactions.
  • Ghisalba O; a Novartis Pharma AG, Research, Core Technology Area, Expertise Bioreactions.
Biosci Biotechnol Biochem ; 63(8): 1497-500, 1999.
Article em En | MEDLINE | ID: mdl-27389513
ABSTRACT
A microbial screening indicated that two fungal strains, Beauveria bassiana DSM 1344=ATCC 7159 and Cunninghamella elegans DSM 1908=ATCC 9245, as well as four bacterial strains belonging to the genus Streptomyces were able to hydroxylate 4,5-dianilinophthalimide (DAPH, CGP52411) to 4-(4'-hydroxyanilino)-5-anilinophthalimide. Cunninghamella elegans DSM 1908 turned out to be the most active biocatalyst and was also able to form the dihydroxy derivative, 4,5-bis(4'-hydroxyanilino)phthalimide. The reaction for the monohydroxylated biotransformation product was carried out on a preparative scale, and the culture conditions for the formation of 4-(4'-hydroxy- anilino)-5-anilinophthalimide with this strain were op-timized.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 1999 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 1999 Tipo de documento: Article